相关实验视频
Updated: Jul 16, 2025

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
702
揭开表面修改策略,防止医疗器械诱导的血栓形成
Cuong Hung Luu1,2, Nam-Trung Nguyen1,2, Hang Thu Ta1,2
1School of Environment and Science, Griffith University, Nathan, Queensland, 4111, Australia.
Advanced healthcare materials
|September 19, 2023
概括
生物材料的血液兼容性对于医疗器械来说至关重要,以防止血液凝块. 本综述探讨了表面修改和新的策略,以改善血液兼容性和减少设备故障.
科学领域:
- 生物材料科学 生物材料科学
- 医疗设备工程 医疗设备工程
- 血液学 血液学 血液学
背景情况:
- 植入的医疗器械通常由于血小板粘附和血液凝结而失败,导致血栓形成.
- 系统性抗凝剂具有局限性,包括增加出血风险,突出了对内在血液相容材料的需求.
研究的目的:
- 在医疗器械上审查血液表面相互作用和凝血的致病性.
- 检查表面修饰技术和抗凝剂涂层机制.
- 讨论预防血液接触生物材料中血栓形成的新策略.
主要方法:
- 关于血液表面相互作用的综合文献综述.
- 对生物材料表面修饰技术的分析.
- 对抗凝血剂涂层机制和新型血栓形成预防策略的评估.
主要成果:
- 血栓形成仍然是血液接触医疗器械的一个重大挑战.
- 表面修饰和抗凝剂涂层是改善血红相容性的关键策略.
- 新的方法旨在防止或调节血液成分与材料表面的相互作用.
结论:
- 开发具有优异血红相容性的生物材料对于长期的医疗器械应用至关重要.
- 未来的研究应该集中在减轻血栓形成和提高器件性能的创新方法上.
- 了解和控制血液物质相互作用对于推进医疗器械技术至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
747
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
747
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
559
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
559
Bacterial Signaling
32.7K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
32.7K
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11

